|
|
Blood, 15 April 2004, Vol. 103, No. 8, pp. 3216-3221.
Prepublished online as a Blood First Edition Paper on December 30, 2003; DOI 10.1182/blood-2003-08-2860.
 Previous Article | Table of Contents | Next Article 
NEOPLASIA
IL-6 levels and genotype are associated with risk of young adult Hodgkin lymphoma
Wendy Cozen,
Parkash S. Gill,
Sue Ann Ingles,
Rizwan Masood,
Otoniel Martínez-Maza,
Myles G. Cockburn,
W. James Gauderman,
Malcolm C. Pike,
Leslie Bernstein,
Bharat N. Nathwani,
Muhammad T. Salam,
Kathleen Lackerdas Danley,
Wei Wang,
Julia Gage,
Susan Gundell-Miller, and
Thomas M. Mack
From the Department of Preventive Medicine, University of Southern California Keck School of Medicine, Los Angeles; Department of Pathology, University of Southern California Keck School of Medicine, Los Angeles; Department of Medicine, University of Southern California Keck School of Medicine, Los Angeles; Departments of Microbiology, Immunology and Molecular Genetics, David Geffen School of Medicine at University of California Los Angeles (UCLA), Los Angeles; and the Departments of Obstetrics and Gynecology, David Geffen School of Medicine at UCLA, Los Angeles.
Identical twins of young adult Hodgkin lymphoma case subjects are much more likely to develop the disease compared with fraternal twins of case subjects, suggesting a genetic determinant. Interleukin 6 (IL-6) levels are increased in patients with Hodgkin lymphoma and are correlated with a poor prognosis. We hypothesized that a heritable abnormality in IL-6 regulation may predispose to young adult Hodgkin lymphoma. We obtained blood specimens from 88 young adult Hodgkin lymphoma case subjects and their twins as well as from 87 matched control subjects. IL-6 was measured from unstimulated peripheral blood mononuclear cell (PBMC) supernatant with enzyme-linked immunosorbent assays (ELISAs) and compared by using analysis of covariance. Unaffected identical twins of case subjects (surrogate case subjects) had a 87.8% higher IL-6 level compared with matched control subjects (mean difference, +483.7 pg/mL, P = .04). Analysis of the IL-6 174G>C promoter polymorphism genotypes showed that risk decreased with an increasing number of C alleles (P = .01). The CC (low secreting) genotype was associated with a decreased risk of young adult Hodgkin lymphoma relative to the GG (high secreting) genotype (odds ratio [OR] = .29; P = .03). Risk was decreased for both nodular sclerosis and other subtypes. Persons with genetically determined lower IL-6 levels may be less susceptible to young adult Hodgkin lymphoma. (Blood. 2004;103:3216-3221)
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
Related Article in Blood Online:
-
Novel twin study implicates IL-6 in the etiology of young adult Hodgkin lymphoma
- James R. Cerhan
Blood 2004 103: 2871-2872.
[Full Text]
[PDF]
This article has been cited by other articles:
|
|
|
|
 
W. Cozen, A. S. Hamilton, P. Zhao, M. T. Salam, D. M. Deapen, B. N. Nathwani, L. M. Weiss, and T. M. Mack
A protective role for early oral exposures in the etiology of young adult Hodgkin lymphoma
Blood,
November 5, 2009;
114(19):
4014 - 4020.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. J. Biggar, J. S. Johansen, K. E. Smedby, K. Rostgaard, E. T. Chang, H.-O. Adami, B. Glimelius, D. Molin, S. Hamilton-Dutoit, M. Melbye, et al.
Serum YKL-40 and Interleukin 6 Levels in Hodgkin Lymphoma
Clin. Cancer Res.,
November 1, 2008;
14(21):
6974 - 6978.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Poulain, I. Dervite, X. Leleu, V. Coiteux, P. Duthilleul, and P. Morel
The IL6(-174G/C) polymorphism is a prognostic factor for survival after treatment initiation in Waldenstrom macroglobulinemia patients aged 65 years or less
Haematologica,
July 1, 2008;
93(7):
1109 - 1111.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Chandra, E. Villanueva, E. Feketova, G. W. Machiedo, G. Hasko, E. A. Deitch, and Z. Spolarics
Endotoxemia down-regulates bone marrow lymphopoiesis but stimulates myelopoiesis: the effect of G6PD deficiency
J. Leukoc. Biol.,
June 1, 2008;
83(6):
1541 - 1550.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Cozen, P. S. Gill, M. T. Salam, A. Nieters, R. Masood, M. G. Cockburn, W. J. Gauderman, O. Martinez-Maza, B. N. Nathwani, M. C. Pike, et al.
Interleukin-2, interleukin-12, and interferon-{gamma} levels and risk of young adult Hodgkin lymphoma
Blood,
April 1, 2008;
111(7):
3377 - 3382.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W.-C. Liao, J.-T. Lin, C.-Y. Wu, S.-P. Huang, M.-T. Lin, A. S.-H. Wu, Y.-J. Huang, and M.-S. Wu
Serum Interleukin-6 Level but not Genotype Predicts Survival after Resection in Stages II and III Gastric Carcinoma
Clin. Cancer Res.,
January 15, 2008;
14(2):
428 - 434.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A.V. Brenner, M.A. Butler, S.S. Wang, A.M. Ruder, N. Rothman, P.A. Schulte, S.J. Chanock, H.A. Fine, M.S. Linet, and P.D. Inskip
Single-nucleotide polymorphisms in selected cytokine genes and risk of adult glioma
Carcinogenesis,
December 1, 2007;
28(12):
2543 - 2547.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S Hohaus, M Giachelia, A Di Febo, M Martini, G Massini, B Vannata, F D'Alo', F Guidi, M Greco, F Pierconti, et al.
Polymorphism in cytokine genes as prognostic markers in Hodgkin's lymphoma
Ann. Onc.,
August 1, 2007;
18(8):
1376 - 1381.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. F. Skibola, J. D. Curry, and A. Nieters
Genetic susceptibility to lymphoma
Haematologica,
July 1, 2007;
92(7):
960 - 969.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R.-O. Casasnovas, N. Mounier, P. Brice, M. Divine, F. Morschhauser, J. Gabarre, J.-Y. Blay, L. Voillat, P. Lederlin, A. Stamatoullas, et al.
Plasma Cytokine and Soluble Receptor Signature Predicts Outcome of Patients With Classical Hodgkin's Lymphoma: A Study From the Groupe d'Etude des Lymphomes de l'Adulte
J. Clin. Oncol.,
May 1, 2007;
25(13):
1732 - 1740.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. E. Grulich, C. M. Vajdic, and W. Cozen
Altered Immunity as a Risk Factor for Non-Hodgkin Lymphoma
Cancer Epidemiol. Biomarkers Prev.,
March 1, 2007;
16(3):
405 - 408.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. H.M. Keegan, S. L. Glaser, C. A. Clarke, R. F. Dorfman, R. B. Mann, J. A. DiGiuseppe, E. T. Chang, and R. F. Ambinder
Body Size, Physical Activity, and Risk of Hodgkin's Lymphoma in Women.
Cancer Epidemiol. Biomarkers Prev.,
June 1, 2006;
15(6):
1095 - 1101.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Grimm, L. Six, C. Tomovski, P. Speiser, E. Joura, R. Zeillinger, G. Sliutz, A. Reinthaller, and L. A. Hefler
A Common Interleukin-6 Promoter Polymorphism in Patients With Vulvar Cancer
Reproductive Sciences,
December 1, 2005;
12(8):
617 - 620.
[Abstract]
[PDF]
|
|
|
|
|
|
|
H. Bruunsgaard
Physical activity and modulation of systemic low-level inflammation
J. Leukoc. Biol.,
October 1, 2005;
78(4):
819 - 835.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Bennermo, C. Held, S. Stemme, C.-G. Ericsson, A. Silveira, F. Green, and P. Tornvall
Genetic Predisposition of the Interleukin-6 Response to Inflammation: Implications for a Variety of Major Diseases?
Clin. Chem.,
November 1, 2004;
50(11):
2136 - 2140.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
